Incyte
Corporation
|
||||
(Name
of Issuer)
|
||||
Common
Stock, par value $0.001 per share
|
||||
(Title
of Class of Securities)
|
||||
45337C102
|
||||
(CUSIP
Number)
|
||||
Leo
Kirby
667
Madison Avenue, 17th Floor
New
York, NY 10065
(212)
339-5633
|
||||
(Name,
Address and Telephone Number of Person Authorized to Receive Notices and
Communications)
|
||||
December
17, 2008
|
||||
(Date
of Event which Requires Filing of this Statement)
|
||||
CUSIP
No. 45337C102
|
Page 2 of 7 Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Julian C. Baker
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a)
o
(b) o
|
|||
3
|
SEC
USE ONLY
|
||||
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
||||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO ITEMS 2(d)
OR 2(e)
|
o
|
|||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
117,917
|
|||
8
|
SHARED
VOTING POWER
16,457,692
|
||||
9
|
SOLE
DISPOSITIVE POWER
117,917
|
||||
10
|
SHARED
DISPOSITIVE POWER
16,457,692
|
||||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,457,692
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
||||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
16.1%
|
||||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
CUSIP
No. 45337C102
|
Page 3 of 7 Pages
|
1
|
NAMES
OF REPORTING PERSONS I.R.S. IDENTIFICATION NOS. OF ABOVE
PERSONS
Felix J. Baker
|
||||
2
|
CHECK
THE APPROPRIATE BOX IF A MEMBER OF A GROUP (See Instructions)
|
(a)
o
(b) o
|
|||
3
|
SEC
USE ONLY
|
||||
4
|
SOURCE
OF FUNDS (See Instructions)
WC
|
||||
5
|
CHECK
BOX IF DISCLOSURE OF LEGAL PROCEEDINGS IS REQUIRED PURSUANT TO
ITEMS
2(d) OR 2(e)
|
o
|
|||
6
|
CITIZENSHIP
OR PLACE OF ORGANIZATION
United
States
|
||||
NUMBER
OF
SHARES
BENEFICIALLY
OWNED
BY
EACH
REPORTING
PERSON
WITH
|
7
|
SOLE
VOTING POWER
0
|
|||
8
|
SHARED
VOTING POWER
16,339,775
|
||||
9
|
SOLE
DISPOSITIVE POWER
0
|
||||
10
|
SHARED
DISPOSITIVE POWER
16,339,775
|
||||
11
|
AGGREGATE
AMOUNT BENEFICIALLY OWNED BY EACH REPORTING PERSON
16,339,775
|
||||
12
|
CHECK
BOX IF THE AGGREGATE AMOUNT IN ROW (11) EXCLUDES CERTAIN SHARES (See
Instructions)
|
||||
13
|
PERCENT
OF CLASS REPRESENTED BY AMOUNT IN ROW (11)
15.9%
|
||||
14
|
TYPE
OF REPORTING PERSON (See Instructions)
IN
|
Item
5.
|
Interest
in Securities of the Issuer.
|
Name
|
Number
of
Shares
|
Percent
of Class
Outstanding
|
||||||
Baker
Bros. Investments I, L.P.
|
144,314 | 0.1 | % | |||||
Baker
Bros. Investments II, L.P.
|
174,248 | 0.1 | % | |||||
667,
L.P.
|
4,574,662 | 4.6 | % | |||||
Baker
Brothers Life Sciences, L.P.
|
10,963,831 | 10.8 | % | |||||
14159,
L.P.
|
267,770 | 0.3 | % | |||||
Baker/
Tisch Investments, L.P.
|
181,540 | 0.1 | % | |||||
FBB
Associates
|
33,410 | 0.0 | % | |||||
Julian
Baker
|
117,917 | 0.1 | % | |||||
|
||||||||
Total
|
16,457,692 | 16.1 | % |
Name
|
Date
|
Number
of
|
||||||||
Shares
|
Transaction
|
Price
/ Share
|
||||||||
Baker
/ Tisch Investments, L.P.
|
12/17/2008
|
62 |
Purchase
|
3.15000 | ||||||
Baker
Bros. Investments II, L.P.
|
12/17/2008
|
13 |
Purchase
|
3.15000 | ||||||
667,
L.P.
|
12/17/2008
|
2,903 |
Purchase
|
3.15000 | ||||||
Baker
Brothers Life Sciences, L.P.
|
12/17/2008
|
9,259 |
Purchase
|
3.15000 | ||||||
14159,
L.P.
|
12/17/2008
|
254 |
Purchase
|
3.15000 | ||||||
Baker
/ Tisch Investments, L.P.
|
12/17/2008
|
543 |
Purchase
|
3.3342 | ||||||
Baker
Bros. Investments II, L.P.
|
12/17/2008
|
112 |
Purchase
|
3.3342 | ||||||
667,
L.P.
|
12/17/2008
|
25,153 |
Purchase
|
3.3342 | ||||||
Baker
Brothers Life Sciences, L.P.
|
12/17/2008
|
80,201 |
Purchase
|
3.3342 | ||||||
14159,
L.P.
|
12/17/2008
|
2,191 |
Purchase
|
3.3342 | ||||||
Baker
/ Tisch Investments, L.P.
|
12/17/2008
|
896 |
Purchase
|
3.3318 | ||||||
Baker
Bros. Investments II, L.P.
|
12/17/2008
|
184 |
Purchase
|
3.3318 | ||||||
667,
L.P.
|
12/17/2008
|
41,510 |
Purchase
|
3.3318 | ||||||
Baker
Brothers Life Sciences, L.P.
|
12/17/2008
|
132,354 |
Purchase
|
3.3318 | ||||||
14159,
L.P.
|
12/17/2008
|
3,616 |
Purchase
|
3.3318 | ||||||
Baker
/ Tisch Investments, L.P.
|
12/18/2008
|
93 |
Purchase
|
3.5966 | ||||||
Baker
Bros. Investments II, L.P.
|
12/18/2008
|
8 |
Purchase
|
3.5966 | ||||||
667,
L.P.
|
12/18/2008
|
3,904 |
Purchase
|
3.5966 | ||||||
Baker
Brothers Life Sciences, L.P.
|
12/18/2008
|
13,055 |
Purchase
|
3.5966 | ||||||
14159,
L.P.
|
12/18/2008
|
355 |
Purchase
|
3.5966 | ||||||
Baker
/ Tisch Investments, L.P.
|
12/18/2008
|
1,535 |
Purchase
|
3.5633 | ||||||
Baker
Bros. Investments II, L.P.
|
12/18/2008
|
125 |
Purchase
|
3.5633 | ||||||
667,
L.P.
|
12/18/2008
|
64,559 |
Purchase
|
3.5633 | ||||||
Baker
Brothers Life Sciences, L.P.
|
12/18/2008
|
215,917 |
Purchase
|
3.5633 | ||||||
14159,
L.P.
|
12/18/2008
|
5,897 |
Purchase
|
3.5633 | ||||||
Baker
/ Tisch Investments, L.P.
|
12/19/2008
|
290 |
Purchase
|
3.6175 | ||||||
Baker
Bros. Investments II, L.P.
|
12/19/2008
|
60 |
Purchase
|
3.6175 | ||||||
667,
L.P.
|
12/19/2008
|
13,433 |
Purchase
|
3.6175 | ||||||
Baker
Brothers Life Sciences, L.P.
|
12/19/2008
|
42,834 |
Purchase
|
3.6175 | ||||||
14159,
L.P.
|
12/19/2008
|
1,170 |
Purchase
|
3.6175 | ||||||
Baker
/ Tisch Investments, L.P.
|
12/19/2008
|
1,637 |
Purchase
|
3.5954 | ||||||
Baker
Bros. Investments II, L.P.
|
12/19/2008
|
337 |
Purchase
|
3.5954 | ||||||
667,
L.P.
|
12/19/2008
|
75,808 |
Purchase
|
3.5954 | ||||||
Baker
Brothers Life Sciences, L.P.
|
12/19/2008
|
241,712 |
Purchase
|
3.5954 | ||||||
14159,
L.P.
|
12/19/2008
|
6,602 |
Purchase
|
3.5954 | ||||||
667, L.P. |
12/22/2008
|
12 | Purchase | 3.2500 | ||||||
Baker Brothers Life Sciences, L.P. |
12/22/2008
|
85 | Purchase | 3.2500 | ||||||
14159, L.P. |
12/22/2008
|
3 | Purchase | 3.2500 |
Name
|
Date
|
Principal
|
||||||||
Amount
of
|
Transaction
|
Price
|
||||||||
Conv.
Notes
|
||||||||||
Baker
/ Tisch Investments, L.P.
|
12/18/2008
|
18,000 |
Purchase
Senior Conv.
|
$ | 52.84 | |||||
Baker
Bros. Investments II, L.P.
|
12/18/2008
|
1,000 |
Purchase
Senior Conv.
|
52.84 | ||||||
667,
L.P.
|
12/18/2008
|
729,000 |
Purchase
Senior Conv.
|
52.84 | ||||||
Baker
Brothers Life Sciences, L.P.
|
12/18/2008
|
2,436,000 |
Purchase
Senior Conv.
|
52.84 | ||||||
14159,
L.P.
|
12/18/2008
|
66,000 |
Purchase
Senior Conv.
|
52.84 | ||||||
Baker
/ Tisch Investments, L.P.
|
12/19/2008
|
52,000 |
Purchase
Senior Conv.
|
52.7583 | ||||||
Baker
Bros. Investments II, L.P.
|
12/19/2008
|
11,000 |
Purchase
Senior Conv.
|
52.7583 | ||||||
667,
L.P.
|
12/19/2008
|
2,383,000 |
Purchase
Senior Conv.
|
52.7583 | ||||||
Baker
Brothers Life Sciences, L.P.
|
12/19/2008
|
7,598,000 |
Purchase
Senior Conv.
|
52.7583 | ||||||
14159,
L.P.
|
12/19/2008
|
206,000 |
Purchase
Senior Conv.
|
52.7583 | ||||||
Baker
/ Tisch Investments, L.P.
|
12/19/2008
|
31,000 |
Purchase
Sub. Conv.
|
51.0342 | ||||||
Baker
Bros. Investments II, L.P.
|
12/19/2008
|
6,000 |
Purchase
Sub. Conv.
|
51.0342 | ||||||
667,
L.P.
|
12/19/2008
|
1,422,000 |
Purchase
Sub. Conv.
|
51.0342 | ||||||
Baker
Brothers Life Sciences, L.P.
|
12/19/2008
|
4,534,000 |
Purchase
Sub. Conv.
|
51.0342 | ||||||
14159,
L.P.
|
12/19/2008
|
124,000 |
Purchase
Sub. Conv.
|
51.0342 |
Exhibit
4.
|
Agreement
regarding the joint filing of this
statement.
|
December
22, 2008
|
|
|
|
By: |
/s/
Julian C. Baker
|
Julian C. Baker | ||
By: |
/s/ Felix J. Baker
|
|
Felix J. Baker |